Stopping a cough depends almost entirely on why you are coughing, and the remedies with the strongest evidence are not the ones most people reach for first. Over-the-counter cough syrups, the go-to for millions of people every cold season, have surprisingly weak evidence behind them, while simpler interventions like honey and menthol have performed respectably in controlled trials. For persistent coughs, the single most effective strategy is treating the underlying cause, whether that turns out to be postnasal drip, a mild form of asthma, acid reflux, or even a blood-pressure medication.
Why Most Over-the-Counter Cough Syrups Disappoint
If you have ever wondered whether that bottle of cough syrup actually did anything, the research largely agrees with your suspicion. A systematic review of randomized controlled trials on over-the-counter cough medicines for acute cough in adults found conflicting evidence across categories and concluded that these products “cannot be recommended because there is no good evidence for their effectiveness,” adding that even when trials showed statistically significant results, the real-world effect was small and of “doubtful clinical relevance.”1PubMed Central. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults
Dextromethorphan, the active cough suppressant in most OTC formulations, illustrates the problem. One study testing it in smokers with cough found that while dextromethorphan did raise the threshold of irritant needed to trigger a cough in a lab setting, there was no significant difference between the drug and placebo when patients rated their own symptoms.2PubMed Central. Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures A more recent narrative review did find that dextromethorphan and guaifenesin, alone or combined, showed statistically significant improvements in cough frequency and mucus looseness compared to placebo across several studies.3PubMed. Guaifenesin and dextromethorphan for management of cough and mucus-related cold symptoms in adults: a narrative literature review So the picture is not completely hopeless, but the effect sizes tend to be modest. If you feel like cough syrup takes the edge off, it might, but if you feel like it does nothing, the research would not argue with you.
Guaifenesin, the expectorant in products like Mucinex, is supposed to thin and loosen mucus so you can cough it up more easily. It remains the only legally marketed expectorant in the United States, and patient studies do support some benefit in conditions with heavy mucus production.4PubMed Central. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections But a comprehensive review noted that “there is limited published evidence of either mechanism of action or clinical efficacy” for guaifenesin in stable chronic bronchitis, despite its FDA monograph indication for that use.5PubMed Central. The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review In short, it may help when you have a wet, productive cough from a cold, but the evidence thins out beyond that.
Codeine Is Not the Gold Standard People Think It Is
For decades, codeine was considered the benchmark cough suppressant, the drug against which everything else was measured. That reputation has not aged well. Recent placebo-controlled studies have shown that codeine is no more effective than placebo for cough caused by upper respiratory infections or chronic lung disease, contradicting older trials that had supported its use.6PubMed Central. Codeine and cough: an ineffective gold standard
Part of the problem is that codeine is a prodrug. Your body has to convert it to morphine for it to work, and people vary wildly in how efficiently they do this. Fast metabolizers can end up with dangerously high morphine levels, while slow metabolizers get almost no active drug at all. This unpredictability prompted the European Medicines Agency to restrict codeine use in children, and the FDA has reviewed its use in pediatric cough-and-cold medicines for the same reason.7European Respiratory Journal. Comprehensive evidence-based review on European antitussives One trial did find codeine outperformed another cough suppressant (levodropropizine) in chronic cough patients, but that same trial noted more side effects in the codeine group, including drowsiness and constipation.8Journal of Korean Medical Science. Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough The evidence, taken together, suggests codeine’s risks and inconsistency outweigh its limited benefits for most people.
Honey and Menthol Have Earned Their Reputation
Honey is one of the few home remedies that has held up under scrutiny, at least for children. A systematic review found low-quality but consistent evidence that honey decreases cough frequency more than placebo or no treatment and also outperforms standard cough medicines, with improved sleep in children as well.9PubMed Central. Honey for acute cough in children – a systematic review In one widely cited trial, honey scored better than both dextromethorphan and no treatment for nighttime cough frequency and sleep quality. Dextromethorphan, by comparison, was not significantly better than doing nothing at all.10Archives of Pediatrics & Adolescent Medicine. Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents One critical caveat: honey should never be given to infants under one year old because of the risk of botulism.
Menthol, the cooling compound in cough drops, eucalyptus rubs, and vapor inhalants, works through a surprisingly specific pathway. Inhaling menthol vapor raised the concentration of irritant needed to trigger a cough by about 25% in one experiment.11PubMed Central. Sweet Taste and Menthol Increase Cough Reflex Thresholds The mechanism appears to involve cold-sensing receptors in the nose, not the lungs. In animal studies, menthol suppressed cough only when it was delivered as vapor to the upper airways; applying it directly to the lower airways had no effect. The researchers concluded that menthol works primarily through a reflex initiated from the nose, mediated by a specific type of sensory receptor called TRPM8.12PubMed Central. The role of trigeminal nasal TRPM8-expressing afferent neurons in the antitussive effects of menthol This explains why breathing in menthol vapor feels like it opens up your airways even though it is not actually changing what is happening in your lungs. The relief is real but the mechanism is a nasal reflex, not a bronchial one.
Treating the Cause Matters More Than Treating the Cough
For coughs that last more than a few weeks, the most effective strategy is almost always figuring out and treating what is driving the cough rather than trying to suppress it with syrups. Three conditions account for the vast majority of chronic coughs in nonsmoking adults with normal chest X-rays: upper airway cough syndrome (often called postnasal drip), a form of asthma that presents mainly as coughing, and gastroesophageal reflux disease.
Postnasal Drip and Upper Airway Cough Syndrome
When mucus draining from the sinuses irritates the throat, the resulting cough can be persistent and annoying. First-generation antihistamine-decongestant combinations are the standard treatment. In one study, over 70% of patients with chronic postnasal drip responded positively to these older-style medications.13PubMed Central. Clinical Aspects of Chronic Idiopathic Postnasal Drip: An Entity Not to Be Overlooked The older antihistamines are preferred over newer ones like cetirizine or loratadine because their anticholinergic properties, the drowsiness-causing side effect most people try to avoid, are actually what dries up the secretions causing the cough. Improvement typically shows up within days to two weeks.14CHEST. Chronic Upper Airway Cough Syndrome Secondary to Rhinosinus Diseases
Cough-Variant Asthma
Some people have a form of asthma in which coughing is the only symptom, with no wheezing or shortness of breath. Inhaled corticosteroids are the primary treatment. In studies of cough-variant asthma, four weeks of inhaled corticosteroid therapy improved airway function, and long-term use appeared to prevent progression to typical asthma. Patients who did not continue inhaled corticosteroids were more likely to develop full-blown asthma over time.15PubMed Central. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids If you have a dry cough that has lingered for months, gets worse at night, or flares with exercise or cold air, it is worth asking your doctor about a trial of inhaled corticosteroids.
Acid Reflux
Gastroesophageal reflux can trigger a cough even when you do not have classic heartburn. Acid reaching the esophagus or even micro-aspirating into the airways irritates nerve endings that trigger the cough reflex. Proton pump inhibitors are the standard treatment, and clinical practice guidelines suggest trying them for at least two to three months at double the standard dose if reflux-related cough is suspected.16PubMed. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough If an empiric trial does not work, that does not necessarily rule out reflux. Guidelines recommend further objective testing, because the initial dose may not have been aggressive enough, or the reflux pattern may be unusual.17PubMed. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines In some cases, surgical repair has resolved cough when intensive medical therapy failed.
When Your Blood-Pressure Medication Is the Culprit
ACE inhibitors, a widely prescribed class of blood-pressure drugs, cause a persistent dry cough in a substantial minority of users. The mechanism involves accumulation of bradykinin and substance P in the airways, which sensitizes airway nerve fibers and triggers bronchoconstriction.18PubMed Central. ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction The cough can appear weeks or even months after starting the medication, which makes it easy to miss the connection. It typically resolves within one to four weeks of switching to a different drug class, most commonly an ARB. If you have been on a medication like lisinopril, enalapril, or ramipril and developed a nagging dry cough that does not respond to anything else, this is one of the first things to consider.
Behavioral Therapy for Chronic Cough
This is the least intuitive remedy on the list, and one of the most effective for people with stubborn, unexplained chronic coughs. Behavioral cough suppression therapy typically involves a speech pathologist or physiotherapist who teaches techniques like controlled breathing, throat relaxation, and cough-suppression strategies. A meta-analysis of 12 randomized controlled trials found that this approach significantly improved cough-related quality of life and reduced objective cough frequency compared to simple verbal education alone.19PubMed Central. Efficacy of behavioral cough suppression therapy for refractory chronic cough or unexplained chronic cough: a meta-analysis of randomized controlled trials
A Cochrane review of speech and language therapy for unexplained chronic cough found a statistically significant benefit at four weeks: patients receiving the intervention coughed about 41% less per hour relative to the control group. The review also reported improvements in symptom scores and overall clinical improvement, though the quality of evidence was rated low due to the small number of studies.20Cochrane Database of Systematic Reviews. Speech and language therapy for unexplained chronic cough The underlying idea is rooted in the neurobiology of cough: changes in how peripheral and central neural circuits regulate cough sensitivity can drive excessive coughing even after the original irritant is gone.21PubMed Central. Peripheral and central mechanisms of cough hypersensitivity Behavioral therapy, in effect, retrains those circuits.
The Placebo Effect Is Enormous in Cough
One reason the cough-medicine aisle stays profitable despite weak evidence is that the placebo effect in cough is exceptionally large. The sweet taste of syrup, the cooling sensation of menthol, the ritual of taking a medicine: all of these can genuinely suppress cough through changes in brain activity involving opioid and dopamine pathways. A review described this powerful placebo effect as both a problem and an opportunity. It is a problem for researchers because any new cough drug has to beat a placebo response that is already substantial. It is an opportunity because the sensory experience of taking a cough medicine, its taste, texture, and smell, can itself be optimized to maximize relief even without a pharmacologically active ingredient.22PubMed Central. The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials
This does not mean cough medicines are useless. It means the line between “real” effect and placebo effect is blurrier for cough than for most symptoms. If a warm cup of tea with honey and lemon makes you cough less, part of that may be the honey’s genuine demulcent action, part may be the warmth and hydration, and part may be your brain’s response to the soothing ritual. From a practical standpoint, who cares which fraction is which? The cough stopped.
What About Children
The safety landscape for children is considerably more restrictive, and for good reason. The FDA has raised concerns about most standard cough-and-cold products in young children. Codeine risks respiratory depression due to the unpredictable metabolizer issue discussed earlier, and dextromethorphan, benzonatate, antihistamines, guaifenesin, and mucolytics either lack efficacy in controlled pediatric trials or simply have no good data to evaluate.23PubMed. Management of Acute Cough in Children: Where Do We Go From Here? For children over one year of age, honey remains one of the few interventions with positive trial data. Beyond that, keeping the child hydrated, using saline nasal drops for congestion, and running a humidifier are the mainstays of evidence-based home care.
Saline, Steam, and Environmental Adjustments
Nebulized hypertonic saline has shown benefit in specific clinical settings. A study of children with acute bronchiolitis found that 3% hypertonic saline nebulization reduced clinical severity scores and shortened hospital stays compared to normal saline or no nebulization.24PubMed Central. Effectiveness of 3% hypertonic saline nebulization in acute bronchiolitis among Indian children: A quasi-experimental study For adults, saline gargling showed significant clinical recovery in a trial of COVID-19 patients, though that study was looking at overall recovery rather than cough specifically.25PubMed Central. Impact of Steam Inhalation, Saline Gargling, and Povidone-Iodine Gargling on Clinical Outcome of COVID-19 Patients in Bengaluru, Karnataka: A Randomized Control Trial
As for broader environmental modifications like air purifiers, humidifiers, or removing irritants from indoor air, these make intuitive sense but lack strong trial evidence. A Cochrane review looking for randomized controlled trials on indoor air modification for prolonged cough in children found zero eligible trials and could not make any recommendation for or against these interventions.26Cochrane Library. Indoor air modification interventions for prolonged non‐specific cough in children That does not mean humidifiers are worthless. It means nobody has done the rigorous trials to prove they help. Avoiding known irritants like cigarette smoke and strong chemical fumes is common-sense advice that does not really need a randomized trial to justify.
New Drugs Targeting Cough at Its Source
The most exciting development in cough treatment is a new class of drugs that block a receptor called P2X3, which sits on the sensory nerves that detect airway irritation and trigger the cough reflex. Gefapixant is the most advanced of these and has been evaluated in a systematic review and dose-response meta-analysis for refractory or unexplained chronic cough.27PubMed Central. Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis It has also been tested in patients with chronic cough lasting a year or less.28PubMed Central. The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough
Another P2X3 antagonist, sivopixant, showed a roughly 31% reduction in 24-hour cough counts compared to placebo in a randomized trial of patients with refractory chronic cough. Quality of life also improved. The main side effect was a mild taste disturbance, which affected a small fraction of participants.29European Respiratory Journal. Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough These drugs represent the first genuinely new approach to cough in decades and could eventually offer real relief to the millions of people with chronic coughs that resist everything else on this list.
Herbal Extracts With Actual Trial Data
Most herbal cough remedies have no controlled evidence behind them, but a few have been tested in proper randomized trials. Pelargonium sidoides extract, sold under the brand name Umckaloabo in parts of Europe, is the standout. A meta-analysis of placebo-controlled trials found that about 80% of children and adolescents with acute bronchitis who received the extract had at least a 50% reduction in cough intensity by day seven, compared to about 41% given placebo. In adults with acute bronchitis, the response rates were roughly 89% versus 48%. Complete cough remission by day seven was several times more common in the treatment groups.30PubMed Central. Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life – a meta-analysis of randomized, placebo-controlled trials
Ivy leaf extract, another herbal remedy popular in Europe and parts of Asia, was tested in a double-blind trial for acute bronchitis. A combination product containing ivy leaf and coptidis rhizome was found to be non-inferior to an established ivy leaf product, with no significant differences in symptom improvement.31PubMed. Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial These herbal options are not magic, and the evidence base is smaller than for conventional medicines, but they do have more rigorous backing than most supplements on pharmacy shelves.
Benzonatate and Combination Approaches
Benzonatate is a prescription cough suppressant that works differently from dextromethorphan or codeine. It numbs stretch receptors in the lungs and airways, reducing the physical sensation that triggers coughing. On its own, one study found it did not significantly suppress cough-reflex sensitivity compared to placebo. But when combined with guaifenesin, the pair suppressed cough to a greater degree than either drug alone, suggesting a synergy that researchers have yet to fully explain.32PubMed. Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough Benzonatate carries real safety risks if misused, particularly in children. Chewing or dissolving the capsules instead of swallowing them whole can cause rapid numbing of the mouth and throat, and overdoses can be fatal.
Acupuncture-related therapies have also accumulated a modest evidence base. A systematic review and meta-analysis found that acupuncture added to conventional treatment significantly improved cough severity and quality of life in chronic cough patients, with no increase in side effects.33PubMed Central. Acupuncture-related therapy for chronic cough: A systematic review and meta-analysis One randomized trial found that electrical stimulation of acupuncture points before a bronchoscopy procedure reduced coughing during the procedure and was associated with higher levels of the body’s own opioid, beta-endorphin.34PubMed Central. Cough Suppression during Flexible Bronchoscopy Using Transcutaneous Electric Acupoint Stimulation: A Randomized Controlled Study The overall quality of evidence for acupuncture remains limited, but the findings at least suggest that non-pharmacological approaches can influence the cough reflex in measurable ways.